Study guide

7.5 Complementary, Alternative & Integrative Therapies

Advanced Oncology Certified Nurse Practitioner AOCNP

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the AOCNP Exam 1.2 How to Use This AOCNP Study Guide

2 Chapter 2: Cancer Continuum - Risk, Prevention & Screening

2.1 Cancer Risk Factors, At-Risk Populations & Health Disparities 2.2 Primary Prevention, Vaccination, Chemoprevention & Risk-Reducing Surgery 2.3 Cancer Screening & Early Detection Guidelines 2.4 Screening for Subsequent & Second Primary Malignancies 2.5 Hereditary Cancer Syndromes & Genetic Counseling

3 Chapter 3: Cancer Continuum - Assessment, Diagnosis & Staging

3.1 Diagnostic Workup, Tissue Biopsy & Biomarker Evaluation 3.2 Pathology Interpretation, Histology & Tumor Grading 3.3 Cancer Staging Systems (TNM) & Prognostication Models 3.4 Performance Status, Frailty & Geriatric Assessment

4 Chapter 4: Cancer Continuum - Planning, Coordination & Survivorship

4.1 Established Guidelines for Care & Categories of Evidence 4.2 Individualized Treatment Planning & Molecular Tumor Boards 4.3 Reproductive Planning & Fertility Preservation 4.4 Patient Navigation & Interprofessional Care Coordination 4.5 Survivorship Care Planning & Late Effects Management 4.6 Post-Treatment Surveillance for Cancer Recurrence

5 Chapter 5: Cancer Treatment - Antineoplastic Pharmacology & Chemotherapy

5.1 Antineoplastic Principles, Dosing & Dose Adjustments 5.2 Cytotoxic Chemotherapy Classes & Adverse Effect Management 5.3 Safe Administration, Handling & Infusion Toxicities 5.4 Oral Antineoplastic Therapy: Adherence, Interactions & Monitoring

6 Chapter 6: Cancer Treatment - Targeted, Immuno & Hormonal Therapies

6.1 Targeted Therapies, Tyrosine Kinase Inhibitors & ADCs 6.2 Cancer Immunotherapy, Checkpoint Inhibitors & CAR T-Cell Therapy 6.3 Endocrine & Hormonal Therapies in Oncology

7 Chapter 7: Cancer Treatment - Radiation, Surgery, Regional & Multimodal Therapy

7.1 Radiation Oncology Principles & Toxicity Management 7.2 Surgical Oncology, Perioperative Care & Reconstruction 7.3 Regional & Localized Therapy Administration 7.4 Multimodal Therapy & Treatment Sequencing 7.5 Complementary, Alternative & Integrative Therapies

8 Chapter 8: Cancer Treatment - Transplantation, Clinical Trials & Response

8.1 Hematopoietic Stem Cell Transplantation (HSCT) & Cell Therapy 8.2 Clinical Trials, Research Protocols & Response Evaluation (RECIST)

9 Chapter 9: Supportive Care - Pain & Controlled Substance Safety

9.1 Cancer Pain Assessment & Comprehensive Analgesic Management 9.2 Controlled Substance Safety & Opioid Stewardship 9.3 Nonpharmacologic & Integrative Symptom Interventions

10 Chapter 10: Supportive Care - Symptom & Comorbidity Management

10.1 Acute, Late & Long-Term Patterns of Treatment-Related Symptoms 10.2 Gastrointestinal Symptom Management (CINV, Mucositis, Diarrhea) 10.3 Hematologic & Neurologic Toxicity Management 10.4 Dermatologic, Metabolic & Fatigue Management 10.5 Cancer-Associated Thrombosis & Anticoagulation 10.6 Comorbid Conditions & Their Interaction With Cancer Treatment 10.7 Palliative Care, Hospice & End-of-Life Management

11 Chapter 11: Oncologic Emergencies

11.1 Superior Vena Cava Syndrome & Structural Emergencies 11.2 Spinal Cord Compression & Neurologic Emergencies 11.3 Metabolic Emergencies: Tumor Lysis Syndrome & Hypercalcemia of Malignancy 11.4 Febrile Neutropenia, Sepsis & Vesicant Extravasation 11.5 Cardiopulmonary & Airway Emergencies 11.6 Hematologic & Endocrine Emergencies: DIC, Leukostasis, Hyperviscosity & SIADH

12 Chapter 12: Psychosocial Issues

12.1 Psychosocial Assessment & Distress Screening in Oncology 12.2 Risk Factors & At-Risk Oncology Populations 12.3 Psychosocial & Emotional Sequelae of Disease and Treatment 12.4 Psychiatric & Psychosocial Comorbidities in Cancer Care 12.5 Caregiver Burden, Support & Community Resources

13 Chapter 13: Professional Practice & Roles of the APRN

13.1 APRN Scope of Practice, Prescriptive Authority & Standards of Care 13.2 Bioethics, Informed Consent & Quality Improvement in Oncology 13.3 Cultural Competence, Implicit Bias & Equitable Oncology Care 13.4 Accreditation Standards & Outcomes of APRN Practice 13.5 Competency Evaluation, Peer Review & Peer Education

7.5 Complementary, Alternative & Integrative Therapies

Key Takeaways Explain This Topic AI

Complementary therapies are used alongside conventional treatment, alternative therapies replace it, and integrative oncology means evidence-based complementary modalities delivered within the cancer care plan.

Patients who choose alternative medicine instead of conventional treatment for curable cancers have substantially worse survival, which makes early non-judgmental disclosure a safety intervention.

St. John's wort is a strong CYP3A4 inducer that can reduce concentrations of many oral kinase inhibitors and other antineoplastics enough to cause treatment failure.

High-dose antioxidant supplementation during radiation or chemotherapy may protect tumor cells and is generally discouraged during active treatment, and beta-carotene increased lung cancer incidence in smokers in randomized trials.

Acupuncture, mindfulness-based stress reduction, yoga, music therapy, and massage have supportive evidence for cancer-related symptoms and are endorsed within evidence-based integrative oncology guidance.

Last updated: August 2026

7.5 Complementary, Alternative & Integrative Therapies

Blueprint focus: ONCC Domain II.H — Complementary, alternative, and integrative therapies. The exam tests three things: the vocabulary, the specific interactions that cause harm, and how the nurse practitioner elicits use without driving it underground.

Getting the Vocabulary Right

  • Term Definition Stance
  • Complementary Used alongside conventional cancer treatment Often appropriate; assess for interactions
  • Alternative Used instead of conventional cancer treatment Dangerous when the cancer is curable

Integrative oncology Evidence-informed complementary modalities delivered within the oncology care plan by trained clinicians The professional standard

The distinction is not semantic. Patients with curable breast, colorectal, lung, or prostate cancer who choose alternative medicine in place of conventional treatment have substantially higher mortality, largely because they refuse or delay surgery, chemotherapy, radiation, or hormone therapy. Recognizing this early — while the window for curative treatment remains open — is a clinical emergency disguised as a values conversation.

Prevalence and the Disclosure Problem

A large majority of patients with cancer use some complementary approach, and a substantial proportion never tell their oncology team , usually because they anticipate dismissal or fear the clinician will withhold treatment. Non-disclosure is the mechanism by which an avoidable interaction becomes an adverse event.

A workable framework:

Normalize. "Most of my patients try something in addition to their treatment. What are you using or thinking about?"

Ask specifically. Vitamins, minerals, herbs, teas, cannabis products, homeopathy, special diets, fasting, acupuncture, chiropractic, energy work, and anything purchased online.

Ask what it is for. A patient taking turmeric for joint pain and one taking it to cure their cancer need entirely different conversations.

Separate safe from unsafe. Endorse what is harmless or helpful. Name the specific risk of what is not.

Offer a substitute. "I can't support high-dose antioxidants during radiation, but I can refer you to our acupuncture service for the same symptom."

Document everything in the medication list, not in a free-text note nobody reads.

Dismissing a modality outright ends disclosure. So does agreeing to something unsafe. The goal is an accurate list plus a specific, reasoned position on each item.

Modalities With Supportive Evidence

Evidence-based integrative oncology guidance from ASCO and the Society for Integrative Oncology supports several modalities for symptom management — never as antineoplastic therapy.

Modality Best-supported uses

Acupuncture and acupressure Chemotherapy-induced nausea and vomiting, aromatase-inhibitor arthralgia, cancer-related pain, hot flashes, chemotherapy-induced peripheral neuropathy symptoms

Mindfulness-based stress reduction and meditation Anxiety, depressive symptoms, sleep disturbance, quality of life

  • Yoga Fatigue, sleep quality, anxiety, quality of life
  • Music therapy Anxiety, procedural distress, pain
  • Massage therapy Pain, anxiety, mood
  • Hypnosis and guided imagery Procedural anxiety, anticipatory nausea, pain

Exercise Cancer-related fatigue (the strongest evidence of any supportive intervention), mood, physical function

Ginger Adjunct for chemotherapy-induced nausea alongside guideline antiemetics

Safety caveats still apply: deep tissue massage is avoided over an irradiated field, an area of thrombocytopenia, or bone metastases; acupuncture requires caution with severe neutropenia or thrombocytopenia and is avoided in a lymphedematous limb; spinal manipulation is contraindicated with vertebral metastases or spinal instability.

Herb and Supplement Interactions That Matter

Product Mechanism Clinical consequence

St. John's wort Strong CYP3A4 inducer and P-glycoprotein inducer Reduces concentrations of imatinib, irinotecan, docetaxel, many kinase inhibitors, and hormonal agents — a documented cause of treatment failure

Grapefruit and Seville orange Irreversible intestinal CYP3A4 inhibitor Raises concentrations and toxicity of many oral agents

Garlic, ginkgo, ginger (high dose), fish oil, vitamin E, dong quai Antiplatelet or anticoagulant effects Bleeding risk, especially with thrombocytopenia or anticoagulation

Green tea extract (high dose EGCG) Proteasome-inhibitor antagonism; hepatotoxicity at high doses May reduce bortezomib activity

Soy isoflavones and black cohosh (concentrated supplements) Phytoestrogen activity Theoretical concern in hormone-receptor-positive disease; dietary soy is not the same as concentrated supplements

Valerian, kava Sedation, hepatotoxicity (kava) Additive sedation with opioids and benzodiazepines; kava-associated liver failure

Turmeric/curcumin (high dose) CYP and P-glycoprotein effects; antiplatelet Interaction and bleeding risk at supplement doses

Cannabis and CBD CYP3A4 and CYP2C9 inhibition Can raise concentrations of some antineoplastics and of warfarin; also additive sedation

Practical rule: ask patients to stop herbal supplements around the time of surgery (commonly 1 to 2 weeks before) and to clear any new supplement with the oncology team before starting it.

The Antioxidant Question

This is a frequent exam item. Radiation and several chemotherapeutic agents kill tumor cells partly through reactive oxygen species . High-dose antioxidant supplementation — vitamin C, vitamin E, beta-carotene, selenium, N-acetylcysteine — could in principle protect tumor cells along with normal cells.

The prevailing recommendation is to avoid high-dose antioxidant supplements during active radiation or chemotherapy , while encouraging an antioxidant-rich diet , which delivers far lower doses.

Beta-carotene supplementation increased lung cancer incidence and mortality in smokers in randomized trials, and is contraindicated in current and former smokers.

Correcting a documented deficiency, such as vitamin D or iron, is entirely different from taking megadoses and should be done.

Communicating About Unproven Cancer "Cures"

When a patient is considering abandoning conventional treatment for an alternative regimen:

Do not argue with the belief; ask what they hope it will do and what worries them about conventional treatment. Fear of chemotherapy toxicity, a bad family experience, distrust rooted in prior discrimination, and cost are the usual drivers — and several are fixable.

State the stakes plainly and once: what the cancer's curability is with treatment, and what is known about outcomes without it.

Offer the integrative alternative that meets the same underlying need, and keep the door open with a scheduled follow-up rather than a discharge.

Preserve the relationship. A patient who feels judged stops coming back, and the opportunity to reconsider disappears with them.

Loading diagram... Assessing and Managing Complementary Therapy Use